Based on above results we proposed a model, in which how TMEPAI may subvert growth suppressive TGF-β signaling in breast cancer cells into growth promotion by inhibiting canonical Smad signaling through R-Smad sequestration and promoting non-canonical PI3K/Akt signaling through PTEN decrease (Fig.10B). Here, AKT1 is linked to breast cancer.